Head-to-head · computed 2026-08-11
Eden vs Henry Meds
Eden: Eden attaches a $99/month membership to tiered medication pricing; all-in figures land at $198 semaglutide and $408 tirzepatide at maintenance. Henry Meds: Henry's all-inclusive semaglutide runs $297/month ($247 on 6-month and $197 on 12-month prepaid bundles) and tirzepatide $349/month; a separately marketed 'as low as $149' microdose floor is a different program.
Tirzepatide
| Eden | Henry Meds | |
|---|---|---|
| All-in maintenance | $408/mo | $179/mo |
| Best plan rate | $408/mo | $179/mo |
| 12-month total | $4,896 | $2,148 |
| Status | Provider-stated · 2026-08-05 | Reported · 2026-07-14 |
The arithmetic
On the figures our desk holds, Henry Meds's $179 a month undercuts Eden's $408 by $229 a month at the 10 mg/wk maintenance basis — $2,748 across a year. Henry Meds's figure is reported (captured 2026-07-14) and Eden's is provider-stated (captured 2026-08-05); a status below 'verified' means our independent checkout capture is still pending, so treat the gap as the best current evidence rather than settled fact.
Eden's tirzepatide ladder runs $408 a month billed monthly. Henry Meds's runs $179 a month billed monthly. On the twelve-month basis Henry Meds's $2,148 beats Eden's $4,896 by $2,748 — with the winner's figure resting on twelve months at the month-to-month rate with no commitment, a structural difference that matters if you might stop early.
Semaglutide
| Eden | Henry Meds | |
|---|---|---|
| All-in maintenance | $198/mo | $179/mo |
| Best plan rate | $198/mo | $197/mo |
| 12-month total | $2,376 | $2,364 |
| Status | Provider-stated · 2026-08-05 | Provider-stated · 2026-08-05 |
The arithmetic
On the figures our desk holds, Eden's $198 a month undercuts Henry Meds's $297 by $99 a month at the 2.4 mg/wk maintenance basis — $1,188 across a year. Eden's figure is provider-stated (captured 2026-08-05) and Henry Meds's is provider-stated (captured 2026-08-05); a status below 'verified' means our independent checkout capture is still pending, so treat the gap as the best current evidence rather than settled fact.
Eden's semaglutide ladder runs $198 a month billed monthly. Henry Meds's runs $297 a month billed monthly, $247 a month on a six-month plan, and $197 a month on a twelve-month plan. On the twelve-month basis Henry Meds's $2,364 beats Eden's $2,376 by $12 — with the winner's figure resting on a committed twelve-month plan, a structural difference that matters if you might stop early.
Where the structures genuinely differ
Henry Meds carries no membership fee against Eden's $99 a month — $1,188 a year of structural cost before any medication ships, which is why this site prices everything all-in. On dose economics, Henry Meds is dose-flat — the price survives titration — while Eden's pricing can move with the dose, a difference that compounds through a standard escalation schedule and matters most to buyers expecting to reach the higher maintenance doses. On exit terms, Eden's structure avoids prepaid lock-in while Henry Meds's better rates ride prepaid terms — cheaper per month, costlier to leave early; read the refund language before choosing the discount.
Structure, side by side
Eden
- Membership$99/mo
- Dose policyTiered on tirzepatide
- CommitmentMonth-to-month
- CancellationCancel anytime
- PharmacyPartner pharmacies
Henry Meds
- MembershipNone
- Dose policyFlat — $179/mo tirzepatide and $179/mo semaglutide at every dose, per reported sources
- CommitmentMonth-to-month; 6/12-month bundles prepaid
- CancellationCancel before renewal; bundle refunds limited
- PharmacyPartner pharmacies
What our desk is watching on each
Eden: Membership plus dose tiering makes Eden's advertised numbers diverge sharply from all-in cost. Open conflict on record: a third-party read of Eden's live treatment page dated July 9, 2026 computed $298/mo all-in tirzepatide ($199 medication + $99 membership) under a new 'Same Price at Every Dose' structure, while our August 5 capture recorded $408 all-in — Eden ran at least three distinct rate structures between April and July 2026, so both figures may have been true on their dates. Flagged for priority re-capture; the later first-party capture stands until then.
Henry Meds: Two independent 2026 captures (RangeYourself Jul 2026, RxPepsDirect May 2026) consistently show $179/mo flat for tirzepatide, replacing our Aug-5 $349 provider-stated figure. Henry's pharmacy partner is not publicly named. Semaglutide plan tiers ($179–$297) remain from our prior captures pending full reconciliation with the updated tirz figure.
Questions people ask
Is Eden or Henry Meds cheaper in 2026?
The tirzepatide and semaglutide verdict blocks above give the computed answer at the maintenance basis, with the verification status of each figure; the short version is that whichever program's all-in monthly number is lower on this page is cheaper on the evidence we hold today, and both rows carry capture dates so you can judge freshness.
What does Eden vs Henry Meds miss that checkout will show?
Taxes, state availability, current promotions, and any dose surcharge introduced after our capture date. Screenshot the order summary before paying — that capture, not any comparison page, is your contract.
Why do you compare at the maintenance dose instead of the starting dose?
Because starter pricing lasts one or two months and maintenance pricing lasts the rest of the year; comparing starts against maintenances is the single most common way GLP-1 comparisons mislead.
What do Eden and Henry Meds cost over a full year of tirzepatide?
On the plans our database holds, a year of tirzepatide runs $4,896 at Eden and $2,148 at Henry Meds — computed from each program's best published twelve-month route, with promotional figures labeled in the sections above and every number carrying its capture date.
Both records live in the normalized database; re-run the math yourself from the downloads. Full record pages: Eden · Henry Meds. Official sites: Eden ↗ · Henry Meds ↗. Nothing here is medical advice.